Orlando, FL -- (SBWIRE) -- 09/04/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Synta Pharmaceuticals Corp.(NASDAQ:SNTA), Rio Tinto plc (ADR)(NYSE:RIO).
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) shares gained 6.10% to $6.26. The company on Aug. 7 announced that the results from an interim survival analysis of the GALAXY-1 trial will be presented at this year's Best of ASCO Meetings in Chicago, Los Angeles, and Boston. GALAXY-1 is a global, randomized Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead drug candidate, ganetespib, as second-line treatment for patients with advanced non-small cell lung adenocarcinoma.
Additionally, the company on Aug. 1 provided clinical updates and reported financial results for the second quarter ended June 30, 2013. There were no revenues recognized in the second quarters of 2013 and 2012. The Company reported a net loss of $22.8 million, or $0.33 per basic and diluted share, in the second quarter of 2013, compared to a net loss of $14.6 million, or $0.25 per basic and diluted share, for the same period in 2012.
Are investors worried about the recent updates with SNTA? Find out with a free trend analysis HERE
Rio Tinto plc (ADR)(NYSE:RIO) shares jumped 5.54% to $47.61. Rio Tinto and Turquoise Hill Resources (Turquoise Hill) on August 7 have signed an agreement under which Rio Tinto will provide Turquoise Hill with a financing package to enable it to fund the continuing development of the Oyu Tolgoi mine in Mongolia and, if necessary, to refinance its existing indebtedness to Rio Tinto by the end of the year.
Additionally, the company on August 8 reported that first-half of 2013 profit before taxation slip to $3.21 billion from $6.75 billion in the prior year period. Profit attributable to owners of the company for the period fell to $1.72 billion from last year's $5.88 billion, with earnings per share declining to 92.6 cents from 315.7 cents in the previous year. Consolidated sales revenue from continuing operations for the period slip to $24.51 billion from $25.32 billion in the prior year period.
Is RIO going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)